Skip to main content

Table 3 Univariable and multivariable analysis of readmission of HF

From: Mitral valve repair and concomitant maze procedure versus catheter ablation in the treatment of atrial functional mitral regurgitation

Variables

Univariable

Multivariable

OR (95% CI)

P value

OR (95% CI)

P value

Age

1.089 (0.998–1.099)

0.3792

  

Male

2.356 (0.425–11.564)

0.2493

  

BSA

2.674 (0.504–11.875)

0.2134

  

Hypertension

2.128 (0.346–6.693)

0.4246

  

Diabetes

1.136 (0.595–4.184)

0.3462

  

COPD

1.245 (0.643–5.743)

0.2522

  

Coronary disease

2.875 (0.612–12.363)

0.2953

  

Renal failure

3.644 (0.960–13.754)

0.0814

  

EuroSCORE II, %

1.321 (0.692–4.643)

0.4257

  

STS PROM score, %

1.295 (0.674–4.256)

0.4369

  

Duration of AF

2.199 (0.358–6.709)

0.4987

  

LA volume

2.985 (1.193–6.938)

0.0421

2.019 (1.008–6.085)

0.0329

LVEDD

2.194 (0.351–6.632)

0.6839

  

LVESD

2.283 (0.401–6.928)

0.7024

  

IVS

1.758 (0.801–5.081)

0.5932

  

LVEF

3.674 (0.977–13.927)

0.0838

  

No MV surgery

5.374 (1.664–15.129)

0.0009

5.062 (1.562–14.671)

0.0011

AF at discharge

3.392 (1.172–9.045)

0.0098

3.151 (1.021–8.283)

0.0124

Moderate-severe MR at discharge

6.013 (2.094–17.125)

0.0003

5.823 (1.968–16.374)

0.0009

Moderate-severe TR at discharge

4.359 (1.903–15.937)

0.0008

4.023 (1.828–15.195)

0.0014

  1. OR odds ratio, CI confidence interval, BSA body surface area, COPD chronic obstructive pulmonary disease, AF atrial fibrillation, LA left atrium, LVEDD left ventricular end diastolic diameter, LVESD left ventricular end systolic diameter, IVS interventricular septum, LVEF left ventricular ejection fraction, MV mitral valve, MR mitral regurgitation, TR tricuspid Regurgitation